<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00987818</url>
  </required_header>
  <id_info>
    <org_study_id>630-190809</org_study_id>
    <nct_id>NCT00987818</nct_id>
  </id_info>
  <brief_title>Procalcitonin Guided Versus Conventional Antibiotic Therapy in Patients With Sepsis in the ICU</brief_title>
  <official_title>Reduction of Antibiotic Use in the ICU: Procalcitonin Guided Versus Conventional Antibiotic Therapy in Patients With Sepsis in the ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rijnstate Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stichting Vrienden van het Alysis Leerhuis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rijnstate Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The adequacy of early empiric antimicrobial therapy is an important factor in determining the
      outcome in patients with severe sepsis. The duration of adequate antibiotic therapy in these
      patients however is less clear. Duration of antibiotic therapy in patients with sepsis in the
      ICU based on inflammatory markers has not been extensively studied.

      Procalcitonin (PCT) is an acute phase protein that has prognostic value in critically ill
      patients and can be used to monitor disease activity in sepsis and systemic inflammation.
      This study will examine the effect of PCT guided antibiotic therapy compared with
      conventional antibiotic therapy on treatment duration in patients with sepsis admitted to the
      ICU.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No MEC approval
  </why_stopped>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>duration of antibiotic therapy</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>28 day mortality</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Sepsis</condition>
  <condition>Intensive Care</condition>
  <arm_group>
    <arm_group_label>PCT guided antibiotic therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard antibiotic therapy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Procalcitonin measurement</intervention_name>
    <description>Daily procalcitonin measurement. Antibiotic discontinuation policy dependent on procalcitonin value. In the control group standard duration of antibiotic therapy.</description>
    <arm_group_label>PCT guided antibiotic therapy</arm_group_label>
    <arm_group_label>Standard antibiotic therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted to the ICU

          -  Age &gt; 18 years

          -  Antibiotic therapy for sepsis with a suspected or proven focus of infection

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Pregnancy

          -  Infection or presumed infection requiring prolonged antibiotic therapy (osteomyelitis,
             meningitis, endocarditis, septic arthritis, mediastinitis, tuberculosis, Pneumocystis
             jiroveci pneumonia, Toxoplasmosis, Legionellosis, Listeriosis)

          -  Indication for prolonged systemic prophylactic antibiotic therapy

          -  Severe viral or parasitic infections (hemorrhagic fever, malaria)

          -  Antibiotic therapy started 48 hours before enrollment

          -  Severe immunocompromised patients (AIDS with a CD4 count &lt; 200cells/mm3, severe
             neutropenia(&lt;500 neutrophils/mm3), patients undergoing immunosuppressive therapy after
             solid organ transplantation)

          -  Patients foregoing life sustaining treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alysis Zorggroep, Rijnstate Hospital</name>
      <address>
        <city>Arnhem</city>
        <state>Gelderland</state>
        <zip>6800TA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2009</study_first_submitted>
  <study_first_submitted_qc>September 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2009</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2015</last_update_posted>
  <responsible_party>
    <name_title>HJ van Leeuwen, MD PhD</name_title>
    <organization>Alysis Zorggroep, Rijnstate Hospital</organization>
  </responsible_party>
  <keyword>Biomarkers</keyword>
  <keyword>Antibiotic therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Calcitonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

